PE20020518A1 - Formulacion en solucion inhalable con una sal de tiotropio - Google Patents

Formulacion en solucion inhalable con una sal de tiotropio

Info

Publication number
PE20020518A1
PE20020518A1 PE2001001072A PE2001001072A PE20020518A1 PE 20020518 A1 PE20020518 A1 PE 20020518A1 PE 2001001072 A PE2001001072 A PE 2001001072A PE 2001001072 A PE2001001072 A PE 2001001072A PE 20020518 A1 PE20020518 A1 PE 20020518A1
Authority
PE
Peru
Prior art keywords
salt
formulation
tiotrope
solvent
water
Prior art date
Application number
PE2001001072A
Other languages
English (en)
Spanish (es)
Inventor
Karin Drechsel
Barbara Niklaus-Humke
Christel Schmelzer
Petra Barth
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7661727&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20020518(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of PE20020518A1 publication Critical patent/PE20020518A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PE2001001072A 2000-10-31 2001-10-29 Formulacion en solucion inhalable con una sal de tiotropio PE20020518A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10054042 2000-10-31

Publications (1)

Publication Number Publication Date
PE20020518A1 true PE20020518A1 (es) 2002-07-12

Family

ID=7661727

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2001001072A PE20020518A1 (es) 2000-10-31 2001-10-29 Formulacion en solucion inhalable con una sal de tiotropio

Country Status (32)

Country Link
EP (1) EP1335729A2 (cs)
JP (1) JP4559703B2 (cs)
KR (1) KR100983208B1 (cs)
CN (1) CN1237970C (cs)
AR (1) AR038765A1 (cs)
AU (2) AU2174102A (cs)
BG (1) BG66425B1 (cs)
BR (1) BR0115016A (cs)
CA (1) CA2427583C (cs)
CZ (1) CZ305033B6 (cs)
DE (1) DE10152369A1 (cs)
EA (1) EA009068B1 (cs)
EC (1) ECSP034570A (cs)
EE (1) EE05343B1 (cs)
HR (1) HRP20030337A2 (cs)
HU (1) HUP0301377A3 (cs)
IL (2) IL155676A0 (cs)
ME (1) ME00242B (cs)
MX (1) MXPA03003750A (cs)
MY (1) MY132777A (cs)
NO (1) NO332524B1 (cs)
NZ (1) NZ526024A (cs)
PE (1) PE20020518A1 (cs)
PL (1) PL361001A1 (cs)
SA (1) SA01220503B1 (cs)
SK (1) SK288031B6 (cs)
TW (1) TWI296934B (cs)
UA (1) UA76435C2 (cs)
UY (1) UY26991A1 (cs)
WO (1) WO2002036591A2 (cs)
YU (1) YU33103A (cs)
ZA (1) ZA200303045B (cs)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1652926T3 (da) 2000-04-28 2010-02-15 Kosan Biosciences Inc Krystallinsk epothilon D
US20030235538A1 (en) 2002-04-09 2003-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Method for the administration of an anticholinergic by inhalation
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
EP1677778A2 (en) * 2003-10-09 2006-07-12 Inverseon, Inc. Method of treating airway diseases with beta-adrenergic inverse agonists
SE0303269L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Medicinsk produkt
AU2006224842B2 (en) * 2005-03-16 2011-09-29 Meda Pharma Gmbh & Co Kg The combination of anticholinergics and leukotriene receptor antagonists for the treatment of respiratory diseases
JP2009538361A (ja) * 2006-05-26 2009-11-05 デイ・リミテッド・パートナーシップ ４級アンモニウムムスカリン受容体アンタゴニストの噴霧可能組成物
CN100446770C (zh) * 2007-01-10 2008-12-31 上海现代药物制剂工程研究中心有限公司 丙酸培氯米松水雾剂
TR200907237A2 (tr) * 2009-09-23 2011-04-21 B�Lg�� Mahmut Tiotropyum kuru toz kombinasyonu
CN116173025A (zh) * 2018-07-26 2023-05-30 四川海思科制药有限公司 一种含格隆铵盐及茚达特罗盐的气雾剂药物组合物及其制备方法与应用
CN116196298A (zh) * 2018-07-26 2023-06-02 四川海思科制药有限公司 一种含格隆铵盐的气雾剂药物组合物及其制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
DE4203306A1 (de) * 1992-02-06 1993-08-12 Ig Spruehtechnik Gmbh Asthma oder pulmonal-aerosolzubereitungen mit lecithin
PT835098E (pt) * 1995-06-27 2002-12-31 Boehringer Ingelheim Pharma Nova composicao farmaceutica estavel para a producao de aerossois sem gas propulsante
US5824669A (en) * 1996-03-22 1998-10-20 Nitromed, Inc. Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
EP0954318A1 (en) * 1996-06-04 1999-11-10 The Procter & Gamble Company A nasal spray containing an intranasal steroid and an antihistamine
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
JPH10298107A (ja) * 1997-04-25 1998-11-10 Taisho Pharmaceut Co Ltd 医薬組成物
US6475467B1 (en) * 1998-08-04 2002-11-05 Jago Research Ag Medicinal aerosol formulations
DE19847968A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Verschlußkappe und Behälter als Zweikammer-Kartusche für Vernebler zur Erzeugung von Aerosolen

Also Published As

Publication number Publication date
MXPA03003750A (es) 2004-10-15
PL361001A1 (en) 2004-09-20
EA009068B1 (ru) 2007-10-26
UY26991A1 (es) 2002-06-20
BR0115016A (pt) 2005-05-03
AU2002221741B2 (en) 2007-04-05
JP2004523482A (ja) 2004-08-05
ECSP034570A (es) 2003-06-25
CA2427583A1 (en) 2002-05-10
BG66425B1 (bg) 2014-04-30
WO2002036591A2 (de) 2002-05-10
KR100983208B1 (ko) 2010-09-20
SK5262003A3 (en) 2003-10-07
IL155676A (en) 2012-05-31
NO332524B1 (no) 2012-10-08
HUP0301377A2 (hu) 2003-10-28
BG107726A (bg) 2004-11-30
ZA200303045B (en) 2004-04-22
CZ305033B6 (cs) 2015-04-08
NO20031914D0 (no) 2003-04-29
TWI296934B (en) 2008-05-21
CN1473044A (zh) 2004-02-04
AR038765A1 (es) 2005-01-26
EP1335729A2 (de) 2003-08-20
MEP40708A (en) 2011-02-10
ME00242B (me) 2011-05-10
JP4559703B2 (ja) 2010-10-13
SK288031B6 (sk) 2012-12-03
HK1060569A1 (en) 2004-08-13
HRP20030337A2 (en) 2005-04-30
NO20031914L (no) 2003-06-23
NZ526024A (en) 2005-10-28
EE05343B1 (et) 2010-10-15
YU33103A (sh) 2006-05-25
EA200300483A1 (ru) 2003-12-25
AU2174102A (en) 2002-05-15
SA01220503B1 (ar) 2007-03-10
MY132777A (en) 2007-10-31
CZ20031487A3 (cs) 2003-09-17
DE10152369A1 (de) 2002-05-08
UA76435C2 (en) 2006-08-15
WO2002036591A3 (de) 2002-07-25
CN1237970C (zh) 2006-01-25
EE200300202A (et) 2003-10-15
KR20040010552A (ko) 2004-01-31
CA2427583C (en) 2008-02-12
HUP0301377A3 (en) 2005-12-28
IL155676A0 (en) 2003-11-23

Similar Documents

Publication Publication Date Title
PE20001226A1 (es) Formulacion liquida con formoterol, apropiada para almacenar
PE20020518A1 (es) Formulacion en solucion inhalable con una sal de tiotropio
BRPI1006790B8 (pt) método para desenvolver uma composição farmacêutica líquida a ser aplicada na pele como uma espuma e composição adequada para uso tópico
Jaenke Delayed and progressive myocardial lesions after adriamycin administration in the rabbit
PE20121396A1 (es) Composicion farmaceutica que comprende bromuro de glicopirronio y formoterol
PE20070643A1 (es) Composiciones farmaceuticas que comprenden buprenorfina
PE20070951A1 (es) Formulacion farmaceutica para aerosoles con dos o mas principios activos y al menos una sustancia tensioactiva
PE20190318A1 (es) Composicion administrable oralmente
JP2007508243A5 (cs)
AR040881A1 (es) Formulacion de anticuerpos humanos para el tratamiento de trastornos asociados con tnf-alfa
PE63998A1 (es) Composiciones anti-fungosas
AR086115A1 (es) Formulaciones parenterales mejoradas de agentes farmaceuticos lipofilos y los metodos para la preparacion y el uso de las mismas
AR098830A2 (es) Suspensiones acuosas estabilizadas para administración parenteral
ES2097548T3 (es) Suspensiones estables de microburbujas como agentes de intensificacion para ecografia ultrasonica.
BRPI0913326C1 (pt) formulação farmacêuticas tópicas contendo uma baixa concentração de peróxido de benzoíla em suspensão aquosa e um solvente orgânico miscível em água
EA200600528A1 (ru) Способ получения водорастворимых дитерпенов и их применение
Sriram et al. Inhaled β2 adrenergic agonists and other cAMP-elevating agents: therapeutics for alveolar injury and acute respiratory disease syndrome?
BRPI0416650A (pt) composição de lipossoma estável para a aplicação de um agente farmacêutico, composição de lipossoma estéril e estável para a aplicação de um agente farmacêutico método para a produção de uma composição de lipossoma estável para a aplicação de um agente farmacêutico, composição farmacêutica, uso de uma composição de lipossoma, dispositivo para conter uma composição de lipossoma estável, kit para a aplicação de um agente farmacêutico a um paciente, método para aumentar a estabilidade de composições de lipossomas, método para a identificação de uma composição de lipossoma estável na fase, composição de lipossoma e composição de lipossoma estável na fase
BR112012015016A8 (pt) Formulação farmacêutica, forma de dosagem farmacêutica entérica e uso de uma formulação
DK1673074T3 (da) Flydende præparat, indeholdende tobramycin
JP2827295B2 (ja) ビタミンａ類含有点眼剤
PE20030092A1 (es) Formulacion de una solucion de inhalacion con una sal de tiotropio
Tharaux et al. Evidence for functional ANP receptors in cultured alveolar type II cells
BRPI0403316A (pt) Formulações de solução farmacêutica em aerossol adequadas para inalação oral ou nasal contendo glucocorticóides estáveis ao armazenamento; método para formulações estabilizantes e uso de um estabilizador
EA022927B1 (ru) Стабильные глазные капли для заживления повреждений роговицы

Legal Events

Date Code Title Description
FG Grant, registration